Search Results - "David, Mauro"

A mid-infrared lab-on-a-chip for dynamic reaction monitoring by Hinkov, Borislav, Pilat, Florian, Lux, Laurin, Souza, Patricia L., David, Mauro, Schwaighofer, Andreas, Ristanić, Daniela, Schwarz, Benedikt, Detz, Hermann, Andrews, Aaron M., Lendl, Bernhard, Strasser, Gottfried

“…Mid-infrared spectroscopy is a sensitive and selective technique for probing molecules in the gas or liquid phase. Investigating chemical reactions in…”
Get full text

Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab by KHAMBATA-FORD, Shirin, GARRETT, Christopher R, TAN, Benjamin R, KRISHNAMURTHI, Smitha S, BURRIS, Howard A, POPLIN, Elizabeth A, HIDALGO, Manuel, BASELGA, Jose, CLARK, Edwin A, MAURO, David J, MEROPOL, Neal, BASIK, Mark, HARBISON, Christopher T, SHUJIAN WU, WONG, Tai W, XIN HUANG, TAKIMOTO, Chris H, GODWIN, Andrew K

“…The antiepidermal growth factor receptor (EGFR) antibody cetuximab shows activity in multiple epithelial tumor types; however, responses are seen in only a…”
Get full text

Surface Protection and Activation of Mid-IR Plasmonic Waveguides for Spectroscopy of Liquids by David, Mauro, Doganlar, Ismael C., Nazzari, Daniele, Arigliani, Elena, Wacht, Dominik, Sistani, Masiar, Detz, Hermann, Ramer, Georg, Lendl, Bernhard, Weber, Walter M., Strasser, Gottfried, Hinkov, Borislav

“…Liquid spectroscopy in the mid-infrared spectral range is a very powerful, yet premature technique for selective and sensitive molecule detection. Due to the…”
Get full text

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study by Aurisicchio, Luigi, Fridman, Arthur, Mauro, David, Sheloditna, Rose, Chiappori, Alberto, Bagchi, Ansuman, Ciliberto, Gennaro

“…Human telomerase reverse transcriptase (hTERT) is an antigen that may represent a target for a novel anti-cancer strategy. A pilot, phase I study tested the…”
Get full text

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer by Papadimitrakopoulou, Vassiliki, Lee, J Jack, Wistuba, Ignacio I, Tsao, Anne S, Fossella, Frank V, Kalhor, Neda, Gupta, Sanjay, Byers, Lauren Averett, Izzo, Julie G, Gettinger, Scott N, Goldberg, Sarah B, Tang, Ximing, Miller, Vincent A, Skoulidis, Ferdinandos, Gibbons, Don L, Shen, Li, Wei, Caimiao, Diao, Lixia, Peng, S Andrew, Wang, Jing, Tam, Alda L, Coombes, Kevin R, Koo, Ja Seok, Mauro, David J, Rubin, Eric H, Heymach, John V, Hong, Waun Ki, Herbst, Roy S

“…By applying the principles of real-time biopsy, biomarker-based, adaptively randomized studies in non-small-cell lung cancer (NSCLC) established by the…”
Get full text

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines by Lenz, Heinz-Josef, Van Cutsem, Eric, Khambata-Ford, Shirin, Mayer, Robert J, Gold, Philip, Stella, Philip, Mirtsching, Barry, Cohn, Allen L, Pippas, Andrew W, Azarnia, Nozar, Tsuchihashi, Zenta, Mauro, David J, Rowinsky, Eric K

“…This multicenter study evaluated the antitumor activity of cetuximab, an immunoglobulin G1 antibody directed at the epidermal growth factor receptor (EGFR), in…”
Get full text

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma by Yu, Shawn, Yu, Menggang, Keane, Barry, Mauro, David M, Helft, Paul R, Harris, William P, Sanoff, Hanna K, Johnson, Matthew S, O'Neil, Bert, McRee, Autumn Jackson, Somasundaram, Ashwin

“…Combination checkpoint inhibition therapy with yttrium-90 (Y90) radioembolization represents an emerging area of interest in the treatment of advanced…”
Get full text

We Never Fail, That Is, Until We Do: Junior and Senior Faculty Proceduralists Share Perspectives by Mauro, David M., Jordan, Sheryl G.

Get full text

Creating an Open-Access Educational Radiology Website for Medical Students: A Guide for Radiology Educators by Mauro, David M., Ellis, Joshua A., Lilly, John F., Dallaghan, Gary L. Beck, Jordan, Sheryl G.

“…Studies of medical school clerkship websites have reported efficient time management, resource utilization, and hands-on activities. We built a website devoted…”
Get full text

Current Approach to Planning Angiography and MAA Administration by Commander, Clayton W., Mauro, David M.

“…Abstract Transarterial radioembolization of primary and secondary hepatic malignancies utilizing yttrium-90 microspheres is a commonly performed treatment by…”
Get full text

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer by Sclafani, Francesco, Kim, Tae Y, Cunningham, David, Kim, Tae W, Tabernero, Josep, Schmoll, Hans J, Roh, Jae K, Kim, Sun Y, Park, Young S, Guren, Tormod K, Hawkes, Eliza, Clarke, Steven J, Ferry, David, Frödin, Jan-Erik, Ayers, Mark, Nebozhyn, Michael, Peckitt, Clare, Loboda, Andrey, Mauro, David J, Watkins, David J

“…Insulin-like growth factor type 1 receptor (IGF-1R) mediates resistance to epidermal growth factor receptor (EGFR) inhibition and may represent a therapeutic…”
Get full text

An interband cascade laser based heterodyne detector with integrated optical amplifier and local oscillator by Dal Cin, Sandro, Windischhofer, Andreas, Pilat, Florian, Leskowschek, Michael, Pecile, Vito F., David, Mauro, Beiser, Maximilian, Weih, Robert, Koeth, Johannes, Marschick, Georg, Hinkov, Borislav, Strasser, Gottfried, Heckl, Oliver H., Schwarz, Benedikt

“…Heterodyne detection based on interband cascade lasers (ICL) has been demonstrated in a wide range of different applications. However, it is still often…”
Get full text

Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab by Lurje, Georg, Nagashima, Fumio, Zhang, Wu, Yang, Dongyun, Chang, Heung M, Gordon, Michael A, El-Khoueiry, Anthony, Husain, Hatim, Wilson, Peter M, Ladner, Robert D, Mauro, David J, Langer, Christiane, Rowinsky, Eric K, Lenz, Heinz-Josef

“…Purpose: Recently, an objective response rate of 12% was reported in a phase II study of cetuximab in patients with epidermal growth factor receptor…”
Get full text

Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results by Boone, Susan L, Rademaker, Alfred, Liu, Dachao, Pfeiffer, Carmen, Mauro, David J, Lacouture, Mario E

“…Biologic agents targeting the epidermal growth factor receptor (EGFR) have emerged as a robust treatment option for various solid tumors. Despite lower…”
Get more information

A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer by Rugo, Hope S., Trédan, Olivier, Ro, Jungsil, Morales, Serafin M., Campone, Mario, Musolino, Antonino, Afonso, Noémia, Ferreira, Marta, Park, Kyong Hwa, Cortes, Javier, Tan, Antoinette R., Blum, Joanne L., Eaton, Lamar, Gause, Christine K., Wang, Zhen, Im, Ellie, Mauro, David J., Jones, Mary Beth, Denker, Andrew, Baselga, José

“…Purpose To evaluate whether adding humanized monoclonal insulin growth factor-1 receptor (IGF-1R) antibody (dalotuzumab) to mammalian target of rapamycin…”
Get full text

ACR Appropriateness Criteria® Dialysis Fistula Malfunction by Higgins, Mikhail C S S, Diamond, Matthew, Mauro, David M, Kapoor, Baljendra S, Steigner, Michael L, Fidelman, Nicholas, Aghayev, Ayaz, Chamarthy, Murthy R K, Dedier, Julien, Dillavou, Ellen D, Felder, Mila, Lew, Susie Q, Lockhart, Mark E, Siracuse, Jeffrey J, Dill, Karin E, Hohenwalter, Eric J

“…The creation and maintenance of a dialysis access is vital for the reduction of morbidity, mortality, and cost of treatment for end stage renal disease…”
Get full text

ACR Appropriateness Criteria® Suspected Upper Extremity Deep Vein Thrombosis by Desjardins, Benoit, Hanley, Michael, Steigner, Michael L, Aghayev, Ayaz, Azene, Ezana M, Bennett, Shelby J, Chandra, Ankur, Hedgire, Sandeep S, Lo, Bruce M, Mauro, David M, Ptak, Thomas, Singh-Bhinder, Nimarta, Suranyi, Pal S, Verma, Nupur, Dill, Karin E

“…This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is…”
Get full text

Subsurface ecosystem resilience: long-term attenuation of subsurface contaminants supports a dynamic microbial community by Yagi, Jane M, Neuhauser, Edward F, Ripp, John A, Mauro, David M, Madsen, Eugene L

“…The propensity for groundwater ecosystems to recover from contamination by organic chemicals (in this case, coal-tar waste) is of vital concern for scientists…”
Get full text

Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients by WINDER, Thomas, WU ZHANG, ROWINSKY, Eric K, LENZ, Heinz-Josef, DONGYUN YANG, YAN NING, BOHANES, Pierre, GERGER, Armin, WILSON, Peter M, POHL, Alexandra, MAURO, David J, LANGER, Christiane

“…The insulin-like growth factor 1 (IGF1) signaling pathway is an important growth-regulatory pathway, which plays a crucial role in colorectal cancer (CRC)…”
Get full text

Anastomosing hemangioma of the liver: An unusual variant in abdominal MRI imaging by Rogers, Tyler, Shah, Neil, Mauro, David, McGinty, Katrina A.

“…The liver is a rare site for anastomosing hemangiomas with only a few cases reported that characterize the lesions on magnetic resonance imaging (MRI). These…”
Get full text